The fight for national pharmacare in Canada is heating up, with advocates refusing to let this crucial promise fade away quietly. The Council of Canadians, a vocal advocate for this cause, is leading the charge, demanding action from Prime Minister Mark Carney and the Liberal government.
In 2019, Justin Trudeau made a bold promise to establish a national pharmacare program, aiming to improve healthcare accessibility and equity across the country. This pledge gained momentum with the passing of the Pharmacare Act in 2024, which outlined a plan to negotiate individual deals with provinces and territories. The initial focus was on covering contraception and diabetes-related medications and devices, a step towards comprehensive coverage.
However, the progress has been uneven. While three provinces and one territory have secured deals, the process has stalled since Mark Carney took office in 2025. Newfoundland and Labrador, in particular, has expressed frustration over the lack of negotiations, with Health Minister Lela Evans emphasizing the need for inclusivity in a national program.
The recent announcement of funding cuts to Prince Edward Island's pharmacare program has further fueled concerns. Federal Health Minister Marjorie Michel's response, stating that these programs are set to end naturally, has been met with skepticism. Advocates like Yvonne Earle, a member of the Council of Canadians, argue that this goes against the original plan outlined in the Pharmacare Act.
"This is not just about politics; it's about the health and well-being of Canadians," Earle emphasizes. "The Atlantic provinces have always been strong supporters of pharmacare, and we believe it's time for them to unite and hold the federal government accountable. Canadians voted for this, and we expect the government to deliver on its promise."
The push for a truly universal pharmacare program, providing comprehensive coverage, is gaining momentum. Advocates are calling on residents to make their voices heard, urging Prime Minister Carney to prioritize this issue and fulfill the government's commitment.
"It's time to take a stand and ensure that healthcare is accessible to all Canadians, regardless of their province or territory," Earle concludes.
The future of national pharmacare hangs in the balance, and the coming months will be crucial in determining whether this promise will be kept or forgotten.
